Health Care & Life Sciences » Pharmaceuticals | Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd. | Balance Sheet

Fiscal year is April-March. All values USD Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
632
920
1,229
1,387
1,423
1,049
Total Accounts Receivable
164
262
284
326
320
277
Inventories
119
123
142
144
146
149
Other Current Assets
137
208
224
142
8
8
Total Current Assets
1,051
1,514
1,878
1,999
1,897
1,483
Net Property, Plant & Equipment
151
153
159
180
194
206
Total Investments and Advances
-
-
115
71
226
304
Intangible Assets
24
20
16
13
14
16
Other Assets
53
46
16
17
16
15
Total Assets
1,284
1,738
2,188
2,290
2,433
2,135
ST Debt & Current Portion LT Debt
12
1
-
-
-
Accounts Payable
21
19
19
16
26
Income Tax Payable
27
76
24
19
21
Other Current Liabilities
193
214
203
175
169
Total Current Liabilities
253
310
245
210
216
Long-Term Debt
6
5
-
-
-
Provision for Risks & Charges
2
2
2
2
2
Deferred Taxes
3
2
2
8
84
Other Liabilities
1
2
1
2
2
Total Liabilities
264
320
251
216
223
Common Equity (Total)
1,016
1,412
1,931
2,067
2,205
Total Shareholders' Equity
1,016
1,412
1,931
2,067
2,205
Total Equity
1,021
1,417
1,937
2,074
2,210
Liabilities & Shareholders' Equity
1,284
1,738
2,188
2,290
2,433
Accumulated Minority Interest
5
6
6
6
5

About Taro Pharmaceutical Industries

View Profile
Address
14 Hakitor Street
Haifa Bay HA 26247
Israel
Employees -
Website http://www.taro.com
Updated 07/08/2019
Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U. S. , Canada, and Israel.